LeMaitre Vascular (LMAT) News Today $100.92 -2.23 (-2.16%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$100.92 0.00 (0.00%) As of 02/20/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period LeMaitre Vascular (LMAT) to Release Earnings on ThursdayLeMaitre Vascular (NASDAQ:LMAT) will be releasing earnings after the market closes on Thursday, February 27, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=659618)February 20 at 1:26 AM | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Rice Hall James & Associates LLCRice Hall James & Associates LLC decreased its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 10.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 235,076 shares of the medical instruments supplier's stock after selling 26February 18 at 6:49 AM | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Congress Asset Management Co.Congress Asset Management Co. raised its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 1.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 722,325 shares of the medical instruments supplier's stock aFebruary 16, 2025 | marketbeat.comLake Street Sticks to Their Buy Rating for Lemaitre Vascular (LMAT)February 14, 2025 | markets.businessinsider.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $94.57 Consensus PT from AnalystsFebruary 14, 2025 | americanbankingnews.comWells Fargo Initiates Coverage of LeMaitre Vascular (LMAT) with Equal-Weight RecommendationFebruary 13, 2025 | msn.comLeMaitre Vascular Hires CFO from LumiraDxFebruary 13, 2025 | marketwatch.comLeMaitre initiated with an Equal Weight at Wells FargoFebruary 13, 2025 | markets.businessinsider.comWells Fargo sets LeMaitre stock at Equal Weight, $95 targetFebruary 13, 2025 | msn.comLeMaitre Vascular Appoints Dorian LeBlanc as CFOFebruary 13, 2025 | tipranks.comLeMaitre Vascular (NASDAQ:LMAT) Now Covered by Wells Fargo & CompanyWells Fargo & Company began coverage on shares of LeMaitre Vascular in a research note on Thursday. They issued an "equal weight" rating and a $95.00 price target on the stock.February 13, 2025 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Buy" by AnalystsShares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) have received a consensus rating of "Buy" from the eight research firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, six have assigned a buy rating and oneFebruary 11, 2025 | marketbeat.comThose who invested in LeMaitre Vascular (NASDAQ:LMAT) five years ago are up 252%February 8, 2025 | finance.yahoo.comConestoga Capital Advisors LLC Has $155.98 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Conestoga Capital Advisors LLC lowered its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 14.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,692,834 shares of the medical instruments supFebruary 3, 2025 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Copeland Capital Management LLCCopeland Capital Management LLC lifted its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 0.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,172,015 shares of the medical instrumentsFebruary 2, 2025 | marketbeat.comAusbil Investment Management Ltd Sells 11,053 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Ausbil Investment Management Ltd lowered its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 83.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,193 shares of the medical instruments supplieFebruary 1, 2025 | marketbeat.comShort Interest in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Rises By 37.5%LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) saw a significant increase in short interest in January. As of January 15th, there was short interest totalling 1,210,000 shares, an increase of 37.5% from the December 31st total of 880,000 shares. Currently, 5.9% of the shares of the stock are sold short. Based on an average daily trading volume, of 157,900 shares, the short-interest ratio is currently 7.7 days.February 1, 2025 | marketbeat.comBaldwin Wealth Partners LLC MA Sells 5,032 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Baldwin Wealth Partners LLC MA reduced its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 63.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,961 shares of the medical instrumJanuary 28, 2025 | marketbeat.comLeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025January 27, 2025 | globenewswire.comLeMaitre Vascular (NASDAQ:LMAT) Has More To Do To Multiply In Value Going ForwardJanuary 24, 2025 | uk.finance.yahoo.comLeMaitre Vascular Inc.January 24, 2025 | wsj.comCantor Fitzgerald Forecasts LMAT FY2025 EarningsLeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) - Analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of LeMaitre Vascular in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn expects that the medical instruJanuary 22, 2025 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of "Moderate Buy" by BrokeragesShares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, six have assJanuary 17, 2025 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Short Interest UpdateLeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,210,000 shares, a growth of 37.5% from the December 15th total of 880,000 shares. Approximately 5.9% of the shares of the stock are sold short. Based on an average daily volume of 157,900 shares, the short-interest ratio is presently 7.7 days.January 16, 2025 | marketbeat.comLeMaitre Vascular: Losing SteamJanuary 15, 2025 | seekingalpha.comJPMorgan Chase & Co. Decreases Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)JPMorgan Chase & Co. trimmed its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 21.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 101,059 shares of the medical instruments supplier's stockJanuary 14, 2025 | marketbeat.comJane Street Group LLC Reduces Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Jane Street Group LLC trimmed its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 50.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,606 shares of the medical instrumentsDecember 28, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Barclays PLCBarclays PLC grew its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 394.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 36,577 shares of the medical instruments supplier's stock after purchasing an additional 29,180 sharesDecember 24, 2024 | marketbeat.comGeode Capital Management LLC Grows Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Geode Capital Management LLC grew its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 4.5% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 542,523 shares of the medical instruments supplierDecember 23, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Moderate Buy" from BrokeragesShares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) have received an average rating of "Moderate Buy" from the nine ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, six have given a bDecember 23, 2024 | marketbeat.comLake Street Reaffirms Their Buy Rating on Lemaitre Vascular (LMAT)December 20, 2024 | markets.businessinsider.comState Street Corp Has $76.36 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)State Street Corp lifted its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 3.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 822,085 shares of the medical instruments supplier's stock after puDecember 18, 2024 | marketbeat.comLeMaitre Vascular Prices $150M Convertible Notes OfferingDecember 17, 2024 | markets.businessinsider.comLeMaitre Vascular (NASDAQ:LMAT) Sees Unusually-High Trading Volume - What's Next?LeMaitre Vascular (NASDAQ:LMAT) Sees Unusually-High Trading Volume - Still a Buy?December 17, 2024 | marketbeat.comLeMaitre Vascular Prices $150 Million Convertible Senior NotesDecember 17, 2024 | markets.businessinsider.comLeMaitre Vascular prices $150M convertible senior notesDecember 17, 2024 | msn.comFmr LLC Buys 8,114 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Fmr LLC boosted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 330.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,568 shares of the medical instruments supplier's stock afteDecember 17, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down - What's Next?LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down - Should You Sell?December 16, 2024 | marketbeat.comLeMaitre Vascular To Offer $150 Mln Of Senior Notes; Pre-Market Stock DownDecember 16, 2024 | markets.businessinsider.comLeMaitre Vascular to Offer $150M in Convertible NotesDecember 16, 2024 | tipranks.comLeMaitre Vascular Announces Proposed Convertible Senior Notes OfferingDecember 16, 2024 | globenewswire.comM&T Bank Corp Takes Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)M&T Bank Corp bought a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 16,699 shares of the medical instruments supplier's stock, valued at approximDecember 15, 2024 | marketbeat.comStifel Financial Corp Purchases 7,060 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)Stifel Financial Corp grew its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 10.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,194 shares of the medical instruments supplier'sDecember 14, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 25.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 35,267 shares of the medicaDecember 14, 2024 | marketbeat.comLeMaitre Vascular (NASDAQ:LMAT) Cut to "Hold" at StockNews.comStockNews.com lowered shares of LeMaitre Vascular from a "buy" rating to a "hold" rating in a report on Friday.December 13, 2024 | marketbeat.comJanus Henderson Group PLC Reduces Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Janus Henderson Group PLC decreased its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 9.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 50,834 shares of the medical instrumenDecember 11, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Has $17.79 Million Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Charles Schwab Investment Management Inc. boosted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 6.3% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 191,511 shares of the medical instruments supplier's stock after puDecember 8, 2024 | marketbeat.comBNP Paribas Financial Markets Has $2.59 Million Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT)BNP Paribas Financial Markets boosted its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 80.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,829 shares of the medical instruments supplier's sDecember 7, 2024 | marketbeat.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Bridgewater Associates LPBridgewater Associates LP lessened its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 65.6% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,083 shares of the medical instruments supplier's stockDecember 3, 2024 | marketbeat.comTownsquare Capital LLC Has $4.45 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)Townsquare Capital LLC increased its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 38.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 47,953 shares of the medical instruments supplieNovember 29, 2024 | marketbeat.com Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address LMAT Media Mentions By Week LMAT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LMAT News Sentiment▼0.700.60▲Average Medical News Sentiment LMAT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LMAT Articles This Week▼44▲LMAT Articles Average Week Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GKOS News STVN News BLCO News INSP News NARI News NVST News PRCT News IRTC News WRBY News LIVN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LMAT) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
